22 completed, 3 unknown, 2 active not recruiting, 2 recruiting. 32 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 32 | Completed 22, Unknown 3, Active not recruiting 2, Recruiting 2, Withdrawn 2, Terminated 1 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
Follow Personal Satisfaction: new trials by email Literature Review of Personal Satisfaction trials Research Report on Personal Satisfaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Two Group Experimental Trial Promoting Sports and Exercise Among Female University Students in Saudi Arabia Counselling sessions - Mental Health | Phase 3 | Active not recruiting | University of Jazan | 30 | 2025-01-01 | 2025-03-12 |
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) Fasedienol Nasal Spray, Placebo Nasal Spray - Social Anxiety Disorder (SAD) | Phase 3 | Completed | VistaGen Therapeutics, Inc. | 238 | 2024-09-16 | 2026-11-04 |
| Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering From Gender Dysphoria hormonal treatment with cross sex hormones (testosterone or oestrogenes) started at 14 years old +/- 6 months, Cross sex hormones ( œstrogenes or testosterone) started at 15.5 years old +/- 6 months - Gender Dysphoria | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 60 | 2024-06-25 | 2026-08-10 |
| Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction Lidocaine Spray: Each ml contained 10 mg lidocaine and ethanol. Applied to the local site to provide anesthesia, Benzocaine spray, Placebo group (control arm) - Pain, Satisfaction | Phase 3 | Completed | TC Erciyes University | 60 | 2024-04-01 | 2025-12-01 |
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) Fasedienol Nasal Spray, Placebo Nasal Spray - Social Anxiety Disorder | Phase 3 | Completed | VistaGen Therapeutics, Inc. | 238 | 2024-03-28 | 2026-11-03 |
| The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III Vitamin D3 Drops, Coriolus Versicolor, Trident SAP 66:33 Lemon - Lung Cancer, Gastric Cancer | Phase 3 | Recruiting | Ottawa Hospital Research Institute | 20 | 2022-04-04 | 2026-01-30 |
| Opioid Analgesic Reduction Study opioid-containing analgesic, two over-the-counter analgesics - Opioid Use | Phase 3 | Completed | Rutgers, The State University of New Jersey | 1815 | 2021-01-04 | 2026-08-31 |
| Homeless Care Management App In-Person Case Management at Homeless Recovery Program, Unlimited Smartphone, Smartphone Based Case Management (SPCM) app - Substance Use Disorders, Mental Health Impairment | Phase 3 | Completed | University of Oklahoma | 403 | 2018-04-27 | 2024-12-19 |
| Superficial Cervical Plexus Blockade for Clavicle Fracture Analgesia Ropivacaine, Normal saline - Pain, Postoperative, Satisfaction | Phase 3 | Withdrawn | University of Alabama at Birmingham | 2018-04-01 | 2018-05-25 | |
| Medical Education Intervention for Medical Students Education of medical humanities - Mental Health | Phase 3 | Unknown | Ming Kuang | 200 | 2015-12-01 | 2016-05-26 |
| Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients PEG-ascorbate 2L, PEG 4L - Diabetes Mellitus, Colonic Diseases | Phase 3 | Completed | Parc de Salut Mar | 158 | 2014-12-02 | 2017-02-23 |
| Diet for Colonoscopy Preparation in Diabetic Patients Low-residue diet, Usual care - Diabetes Mellitus, Colonic Diseases | Phase 3 | Completed | Parc de Salut Mar | 150 | 2014-12-01 | 2016-04-12 |
| Effect of Pectoral Electrostimulation on Reduction of Mammary Ptosis PENS, Specific training - Satisfaction | Phase 3 | Completed | Hospital General Universitario Elche | 45 | 2014-01-01 | 2015-05-05 |
| Recruiting to Clinical Trials on the Telephone telephone, consultation face-to-face - Parental Consent, Newborn | Phase 3 | Completed | Gorm Greisen | 125 | 2013-07-01 | 2015-10-07 |
| VA Augmentation and Switching Treatments for Improving Depression Outcomes Switching: Bupropion-SR, Augmenting: Antidepressant + Bupropion-SR, Augmenting: Antidepressant + Aripiprazole - Major Depressive Disorder | Phase 3 | Completed | VA Office of Research and Development | 1522 | 2012-12-01 | 2018-05-29 |
| Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy Oral alprazolam, Sublingual alprazolam, Oral placebo - Diagnostic Esophagogastroduodenoscopy | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 220 | 2011-09-01 | 2013-10-18 |
| Efficacy of a Nurse-based, Anesthesiologist-supervised Acute Pain Service for Pediatric Patients model of health care service - Postoperative Pain, Satisfaction | Phase 3 | Unknown | Mahidol University | 103 | 2011-03-01 | 2011-03-29 |
| Relaxation for Women With Breast Cancer Undergoing Radiotherapy Relaxation Program, Questionnaires, Saliva Testing - Breast Cancer | Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 681 | 2011-02-10 | 2026-10-07 |
| Efficacy of System Constellations in a General Population system constellations seminar - Psychological Well-being | Phase 2 / Phase 3 | Completed | Heidelberg University | 216 | 2011-02-01 | 2012-02-09 |
| Mindfulness-based Stress Reduction for Pediatric Mental Health Mindfulness-based stress reduction program, Usual care - Mental Health Wellness 1 | Phase 3 | Completed | University of Alberta | 85 | 2011-01-01 | 2013-12-10 |
Showing 20 of 32. Sign in to see all of them.
Psychological Well-Being (18) · Anxiety Disorders (4) · Mental Disorders (4) · Pain (3) · Phobia, Social (3) · Colonic Diseases (2) · Delirium (2) · Diabetes Mellitus (2) · Migraine Disorders (2) · Motor Activity (2) · Nervous System Diseases (2) · Pain, Postoperative (2) · Patient Compliance (2) · Agnosia (1)
Behavior (32) · Mental Disorders (11) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (8) · Neurologic Manifestations (7) · Nervous System Diseases (5) · Digestive System Diseases (4) · Gastrointestinal Diseases (4) · Pathologic Processes (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Intestinal Diseases (3) · Metabolic Diseases (3) · Neoplasms (3)
Dexmedetomidine (3) · Naproxen (2) · Saline Solution (2) · Sodium Chloride (2) · Sumatriptan (2) · Alendronate (1) · Alprazolam (1) · Amyloid (1) · Aripiprazole (1) · Curcumin (1) · Denosumab (1) · Educational Status (1) · Exercise (1) · Fish Oils (1) · Golytely (1)
GlaxoSmithKline (2) · Hospira, now a wholly owned subsidiary of Pfizer (2) · Parc de Salut Mar (2) · VistaGen Therapeutics, Inc. (2) · Amgen (1) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Cleveland Clinic Florida (1) · Emory University (1) · Gorm Greisen (1) · Heidelberg University (1) · Hospital General Universitario Elche (1) · Isfahan University of Medical Sciences (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · M.D. Anderson Cancer Center (1)
United States (15) · Canada (3) · Spain (2) · Thailand (2) · Australia (1) · France (1) · Germany (1) · Iran (1) · Saudi Arabia (1) · Taiwan (1) · Turkey (Türkiye) (1)
Ahmad Shavakhi, M.D. (1) · Akarachaid Pinidbunjerdkool, MD (1) · Andrew Seely, MD, PhD, FRCSC (1) · Benjamin G. Druss, MD, MPH (1) · Cecile A Feldman, DMD (1) · Chananya Potisuk (1) · Christopher A Godlewski, MD (1) · Dugald Seely, ND, MSc (1) · Emily Ashby, BPhysio (1) · Jaime Ruiz-Tovar, MD, PhD (1) · Jennifer M Reingle, Ph.D. (1) · Jochen Schweitzer-Rothers, Professor (1)
PMID 20855373, PMID 17606657, PMID 17606658, PMID 18312044, PMID 20008945, PMID 20056720, PMID 20606677, PMID 24251855, PMID 24977401, PMID 27479536, PMID 27490086, PMID 27871308, PMID 28697253, PMID 29871852, PMID 30695291, PMID 30947531, PMID 31665314, PMID 32603560, PMID 32677243, PMID 33225492, PMID 34246265, PMID 35177108, PMID 35366613, PMID 37859623, PMID 39755971, PMID 40742171
2019 (1), 5UH3DE028860-05 (1), R01MD010733 (1), R01MH070437 (1), T32CA009666 (1)